Skip to main content
Premium Trial:

Request an Annual Quote

Coriell Establishes West Coast Biobank

NEW YORK (GenomeWeb News) – The Coriell Institute for Medical Research is launching a biobank on the West Coast that will house induced pluripotent stem cell lines, and is using a $10 million grant from the California Institute of Regenerative Medicine to fund the facility.

Coriell, based in Camden, NJ, said on Thursday it is leasing a renovated 1,000-square-foot space at the Buck Institute for Research on Aging in Novato, Calif., to house the biobanking facility.

The institute said its biobank in California will house the world's largest collection of iPS cell lines. Currently, Coriell is host to 83 such lines, but it plans for the satellite biobank in California to expand its capacity to a total of 9,000 lines.

CIRM, an independent state-supported stem cell research funding agency, awarded the $10 million to Coriell in early 2013, alongside a $16 million award to Cellular Dynamics of Madison, Wis., which will create iPS cell lines for 3,000 healthy and diseased donors.

Under the terms of the grant, Coriell will establish the biorepository, which will manage, track, store, and distribute the iPS cell lines that CDI generates, which will represent a wide range of disease areas.

Coriell said it plans to begin accepting and processing samples at the new facility today.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more